AGP Closes $150 Mn Healthcare Fund, Raises AUM to $350 Mn

The newly closed healthcare fund is focused on emerging opportunities in areas such as healthtech, advanced manufacturing, digital health, and precision medicine.

Singapore-based investment firm August Global Partners (AGP) has successfully closed its flagship healthcare fund at $150 million, bringing its total assets under management (AUM) to $350 million.

The newly closed fund marks the second for AGP and drew participation from a wide range of investors, including financial, institutional, and strategic investors across Asia, Europe, and North America.

The first fund, which incorporated several legacy assets transferred from Singapore’s EDBI after AGP’s spinoff, has invested in companies across healthcare and deep-technology sectors.

The newly closed healthcare fund is focused on emerging opportunities in areas such as healthtech, advanced manufacturing, digital health, and precision medicine.

Reportedly, the new fund is already being deployed in backing companies in genomics, diagnostics, digital health, and medical-technology fields.

Among its early investments are Gene Solutions, a Vietnam-based genomics and diagnostics firm, and Ultragreen.ai, a medical-imaging and fluorescence-guided surgery company.

Highlighting AGP’s investment landscape, Chu Swee Yeok, Chair and Founding Partner at AGP, said, “AGP stands apart through our deep sector expertise, trusted global networks, and the commercial agility to navigate the complexities of the healthcare landscape. We are deeply grateful to our investors and partners for their continued confidence in our strategy and leadership.”

The new fund, anchored in the investment theme ‘Living Better, Aging Better,’ aims to support emerging models in genomics, oncology, AI-driven wearables, medtech, and specialised healthcare delivery to address the needs of the ageing population.

Commenting on the new infusion, Dr. Basil Lui, another founding partner at AGP, said, “Looking ahead, the convergence of medical technology, digital health, AI, and Asia’s demographic transformation presents unprecedented opportunities for innovation and growth. AGP intends to focus on high-growth companies working on preventive healthcare, chronic-disease management, and futuristic medtech solutions.”

Stay tuned for more such updates on Digital Health News